{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:34:59Z","timestamp":1791167699093,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/ajg.2010.303","type":"journal-article","created":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T11:12:40Z","timestamp":1281438760000},"page":"2610-2616","source":"Crossref","is-referenced-by-count":146,"title":["Potential Association Between the Oral Tetracycline Class of Antimicrobials Used to Treat Acne and Inflammatory Bowel Disease"],"prefix":"10.14309","volume":"105","author":[{"given":"David J","family":"Margolis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Hoffstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210210","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0190-9622(98)70442-6","article-title":"Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris.","volume":"39","author":"White","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"R2-16-20210210","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/00015550252948121","article-title":"A community-based epidemiological study of acne vulgaris in Hong Kong adolescents.","volume":"82","author":"Yeung","year":"2002","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"R3-16-20210210","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0190-9622(92)70135-3","article-title":"The prevalence of acne on the basis of physical examination.","volume":"26","author":"Stern","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"R4-16-20210210","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","article-title":"Management of acne: a report from a global alliance to improve outcomes in acne.","volume":"49","author":"Gollnick","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R5-16-20210210","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1572-0241.2006.00632.x","article-title":"Possible association between isotretinoin and inflammatory bowel disease.","volume":"101","author":"Reddy","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R6-16-20210210","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/gut.2008.170530","article-title":"Isotretinoin and intestinal inflammation: what gastroenterologists need to know.","volume":"58","author":"Shale","year":"2009","journal-title":"Gut"},{"key":"R8-16-20210210","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1038\/ajg.2009.334","article-title":"A causal association between isotretinoin and inflammatory bowel disease has yet to be established.","volume":"104","author":"Crockett","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R9-16-20210210","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1038\/ajg.2009.417","article-title":"Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study.","volume":"104","author":"Bernstein","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R10-16-20210210","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199704173361607","article-title":"Therapy for acne vulgaris.","volume":"336","author":"Leyden","year":"1997","journal-title":"N Engl J Med"},{"key":"R11-16-20210210","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/gut.2003.025239","article-title":"Antibiotic use and the development of Crohns disease.","volume":"53","author":"Card","year":"2004","journal-title":"Gut"},{"key":"R12-16-20210210","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of the Health Improvement Network (THIN) database for pharmacoepidemiology research.","volume":"16","author":"Lewis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R13-16-20210210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/pds.698","article-title":"Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease.","volume":"11","author":"Lewis","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R14-16-20210210","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/pds.1784","article-title":"Re, V III, Haynes K, Forde KA et al. Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection.","volume":"18","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R15-16-20210210","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/pds.1919","article-title":"Validation of ischemic cerebrovascular diagnoses in the Health Improvement Network (THIN).","volume":"19","author":"Ruigomez","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R16-16-20210210","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/pds.1686","article-title":"Validation of death and suicide recording on the THIN UK primary care database.","volume":"18","author":"Hall","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R17-16-20210210","first-page":"437","article-title":"Agreement between GPRD smoking data.","volume":"13","author":"Lewis","year":"2004","journal-title":"PDS"},{"key":"R18-16-20210210","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/pds.1774","article-title":"Cancer incidence in the Health Improvement Network.","volume":"18","author":"Haynes","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R19-16-20210210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000018387","article-title":"Minocycline-induced lupus. A systematic review.","volume":"200","author":"Schlienger","year":"2000","journal-title":"Dermatology"},{"key":"R20-16-20210210","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archinte.159.5.493","article-title":"Minocycline and lupus-like syndrome in acne patients.","volume":"159","author":"Sturkenboom","year":"1999","journal-title":"Arch Intern Med"},{"key":"R21-16-20210210","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2133.2007.08056.x","article-title":"Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus.","volume":"157","author":"Margolis","year":"2007","journal-title":"Br J Dermatol"},{"key":"R22-16-20210210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.0926-9959.2001.00013.x","article-title":"Current issues in antimicrobial therapy for the treatment of acne.","volume":"15","author":"Leyden","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R23-16-20210210","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bmj.39048.540394.BE","article-title":"Dont use minocycline as first line oral antibiotics in acne.","volume":"334","author":"McManus","year":"2007","journal-title":"BMJ"},{"key":"R24-16-20210210","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: nonantibiotic properties and their clinical implications.","volume":"54","author":"Sapadin","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R25-16-20210210","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.291.7.827","article-title":"Antibiotic use in relation to the risk of breast cancer.","volume":"291","author":"Velicer","year":"2004","journal-title":"JAMA"},{"key":"R26-16-20210210","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archderm.141.9.1132","article-title":"Antibiotic treatment of acne may be associated with upper respiratory tract infections.","volume":"141","author":"Margolis","year":"2005","journal-title":"Arch Dermatol"},{"key":"R27-16-20210210","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1086\/510385","article-title":"The role of microbes in Crohns disease.","volume":"44","author":"Eckburg","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R28-16-20210210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/gast.2002.30294","article-title":"Mucosal flora in inflammatory bowel disease.","volume":"122","author":"Swidsinski","year":"2002","journal-title":"Gastroenterology"},{"key":"R29-16-20210210","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2007.11.059","article-title":"Microbial influences in inflammatory bowel diseases.","volume":"134","author":"Sartor","year":"2008","journal-title":"Gastroenterology"},{"key":"RU30-16-20210210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000063890","article-title":"Minocycline-induced lupus and autoimmune hepatitis: family autoimmune disorders as possible risk factors.","volume":"205","author":"Bachmeyer","year":"2002","journal-title":"Dermatology"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2010303.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2010303","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2010303.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201012000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:34:26Z","timestamp":1786541666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201012000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2010.303","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}